$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
尼拉帕尼治疗卵巢癌的疗效
2025-10-19 11:44:20
Check Details
奥拉帕尼治疗BRCA突变卵巢癌效果优于安慰剂
2025-10-19 11:44:20
Check Details
奥拉帕尼延长患者的无进展生存期
2025-10-19 11:44:20
Check Details
卡博替尼治疗卵巢癌的有效性
2025-10-19 11:44:20
Check Details
尼拉帕尼治疗复发性上皮性卵巢癌
2025-10-19 11:44:20
Check Details
奥拉帕尼延长卵巢癌患者无进展生存期
2025-10-19 11:44:20
Check Details
尼拉帕尼的推荐剂量
2025-10-19 11:44:20
Check Details
尼拉帕尼治疗卵巢癌临床试验
2025-10-19 11:44:20
Check Details
卵巢癌患者治疗药物-奥拉帕尼
2025-10-19 11:44:20
Check Details
尼拉帕尼改善卵巢癌患者的无进展生存期
2025-10-19 11:44:20
Check Details
奥拉帕尼治疗BRCA突变晚期卵巢癌患者
2025-10-19 11:44:20
Check Details
尼拉帕尼延长卵巢癌患者的无进展生存时间
2025-10-19 11:44:20
Check Details
1
2
...
762
763
764
765
766
767
768
...
4151
4152
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Fulvestrant (Faslodex) Breast Cancer Guide: Indications, Dosage and Safety Specifications
2
Adagrasib (Krazati): Full Guide to KRAS G12C Inhibitor for Cancer Treatment
3
Comprehensive Analysis of the Third-Generation EGFR-TKI
4
ATOMIC Study: Atezolizumab Plus Chemo Improves DFS in dMMR Stage III Colon Cancer
5
Oncology Immunotherapy vs Anti-Inflammatory Biologic: Dostarlimab vs Secukinumab - A Mechanism-Centered Comparison
6
Third-Generation TKI Redefining Treatment for ALK+ & ROS1+ NSCLC
7
Brigatinib Medication Case Study: Three-Year Treatment Record and Experience Sharing of ALK-Positive Lung Cancer Patient
8
What is Brigatinib (Alunbrig)? Complete Guide to ALK-Positive Lung Cancer Targeted Therapy & Medication Guidelines
9
Repotrectinib (Augtyro) Complete Medication Guide 2026: Import Original Drug Price, Eligible Patients & Full Usage Information
10
Ceritinib Capsule Storage Conditions & Expiration Guide: Room Temperature Storage, No Refrigeration Needed
11
Selumetinib for NF1 Treatment: Complete Guide to Targeted Therapy for Type 1 Neurofibromatosis
12
Alectinib for ALK-Positive Lung Cancer: Efficacy, Side Effects & Clinical Outlook